Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Top Cited Papers
Open Access
- 2 August 2021
- journal article
- review article
- Published by Elsevier BV in Immunity
- Vol. 54 (8), 1636-1651
- https://doi.org/10.1016/j.immuni.2021.07.017
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health and Human Services (63/140,250, PCT/US2021/017709, WO/2018/081318)
- Centers for Disease Control and Prevention
- National Institute of Allergy and Infectious Diseases
- Biomedical Advanced Research and Development Authority
- National Institutes of Health
This publication has 111 references indexed in Scilit:
- A proof of concept for structure-based vaccine design targeting RSV in humansScience, 2019
- mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery, 2018
- Emerging viral diseases from a vaccinology perspective: preparing for the next pandemicNature Immunology, 2017
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigenProceedings of the National Academy of Sciences of the United States of America, 2017
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial VirusScience, 2013
- Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyScience, 2013
- Vaccines: the Fourth CenturyClinical and Vaccine Immunology, 2009
- The 1918 Influenza Virus: A Killer Comes into ViewVirology, 2000
- Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.2000
- Synthesis and assembly of hepatitis B virus surface antigen particles in yeastNature, 1982